Arbutus Biopharma
ABUS
#6318
Rank
HK$4.89 B
Marketcap
HK$25.56
Share price
-1.35%
Change (1 day)
18.68%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -HK$0.55 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are HK$6.17 Million. , an increase over its 2023 earnings that were of -HK$0.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -HK$0.55 Billion-4.02%
2023 -HK$0.57 Billion12.05%
2022 -HK$0.51 Billion-14.74%
2021 -HK$0.6 Billion19.61%
2020 -HK$0.5 Billion-61.69%
2019 -HK$1.3 Billion171.23%
2018 -HK$0.48 Billion-43.58%
2017 -HK$0.85 Billion-77.77%
2016 -HK$3.8 Billion532.77%
2015 -HK$0.6 Billion99.05%
2014 -HK$0.31 Billion175.82%
2013 -HK$0.11 Billion-143.7%
2012 HK$0.24 B-399.11%
2011 -HK$83.57 Million-39.03%
2010 -HK$0.14 Billion100.55%
2009 -HK$68.34 Million-28.56%
2008 -HK$95.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$0.27 B-150.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$16.77 Million-96.91% Bahamas